<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36498933</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>23</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>23</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Emerging Roles for the RNA-Binding Protein HuD (ELAVL4) in Nervous System Diseases.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">14606</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms232314606</ELocationID><Abstract><AbstractText>The main goal of this review is to provide an updated overview of the involvement of the RNA-binding protein (RBP) HuD, encoded by the ELAVL4 gene, in nervous system development, maintenance, and function, and its emerging role in nervous system diseases. A particular focus is on recent studies reporting altered HuD levels, or activity, in disease models and patients. Substantial evidence suggests HuD involvement in Parkinson's disease (PD), Alzheimer's disease (AD), and amyotrophic lateral sclerosis (ALS). Interestingly, while possible disease-causing mutations in the ELAVL4 gene remain elusive, a common theme in these diseases seems to be the altered regulation of HuD at multiple steps, including post-transcriptional and post-translational levels. In turn, the changed activity of HuD can have profound implications for its target transcripts, which are overly stabilized in case of HuD gain of function (as proposed in PD and ALS) or reduced in case of decreased HuD binding (as suggested by some studies in AD). Moreover, the recent discovery that HuD is a component of pathological cytoplasmic inclusion in both familial and sporadic ALS patients might help uncover the common molecular mechanisms underlying such complex diseases. We believe that deepening our understanding of the involvement of HuD in neurodegeneration could help developing new diagnostic and therapeutic tools.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silvestri</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Life Nano &amp; Neuro-Science, Fondazione Istituto Italiano di Tecnologia (IIT), 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mochi</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garone</LastName><ForeName>Maria Giovanna</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0002-2101-4474</Identifier><AffiliationInfo><Affiliation>Department of Stem Cell Biology, Murdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, VIC 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosa</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9999-7223</Identifier><AffiliationInfo><Affiliation>Department of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Life Nano &amp; Neuro-Science, Fondazione Istituto Italiano di Tecnologia (IIT), 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067779">ELAV-Like Protein 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C498010">ELAVL4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067779" MajorTopicYN="Y">ELAV-Like Protein 4</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">ELAVL4</Keyword><Keyword MajorTopicYN="N">HuD</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">RNA-binding protein</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>11</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36498933</ArticleId><ArticleId IdType="pmc">PMC9736382</ArticleId><ArticleId IdType="doi">10.3390/ijms232314606</ArticleId><ArticleId IdType="pii">ijms232314606</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bronicki L.M., Jasmin B.J. Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction. RNA. 2013;19:1019&#x2013;1037. doi: 10.1261/rna.039164.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.039164.113</ArticleId><ArticleId IdType="pmc">PMC3708524</ArticleId><ArticleId IdType="pubmed">23861535</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmohsen K., Hutchison E.R., Lee E.K., Kuwano Y., Kim M.M., Masuda K., Srikantan S., Subaran S.S., Marasa B.S., Mattson M.P., et al. miR-375 inhibits differentiation of neurites by lowering HuD levels. Mol. Cell Biol. 2010;30:4197&#x2013;4210. doi: 10.1128/MCB.00316-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00316-10</ArticleId><ArticleId IdType="pmc">PMC2937556</ArticleId><ArticleId IdType="pubmed">20584986</ArticleId></ArticleIdList></Reference><Reference><Citation>Deschenes-Furry J., Perrone-Bizzozero N., Jasmin B.J. The RNA-binding protein HuD: A regulator of neuronal differentiation, maintenance and plasticity. Bioessays. 2006;28:822&#x2013;833. doi: 10.1002/bies.20449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.20449</ArticleId><ArticleId IdType="pubmed">16927307</ArticleId></ArticleIdList></Reference><Reference><Citation>Akamatsu W., Fujihara H., Mitsuhashi T., Yano M., Shibata S., Hayakawa Y., Okano H.J., Sakakibara S.-I., Takano H., Takano T., et al. The RNA-binding protein HuD regulates neuronal cell identity and maturation. Proc. Natl. Acad. Sci. USA. 2005;102:4625&#x2013;4630. doi: 10.1073/pnas.0407523102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0407523102</ArticleId><ArticleId IdType="pmc">PMC555491</ArticleId><ArticleId IdType="pubmed">15764704</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda-Abreu G.E., Behar L., Chung S., Furneaux H., Ginzburg I. Embryonic lethal abnormal vision-like RNA-binding proteins regulate neurite outgrowth and tau expression in PC12 cells. J. Neurosci. 1999;19:6907&#x2013;6917. doi: 10.1523/JNEUROSCI.19-16-06907.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.19-16-06907.1999</ArticleId><ArticleId IdType="pmc">PMC6782881</ArticleId><ArticleId IdType="pubmed">10436048</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson K.D., Sengupta J., Morin M., Neve R.L., Valenzuela C.F., Perrone-Bizzozero N.I. Overexpression of HuD accelerates neurite outgrowth and increases GAP-43 mRNA expression in cortical neurons and retinoic acid-induced embryonic stem cells in vitro. Exp. Neurol. 2001;168:250&#x2013;258. doi: 10.1006/exnr.2000.7599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2000.7599</ArticleId><ArticleId IdType="pubmed">11259113</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone-Bizzozero N.I., Tanner D.C., Mounce J., Bolognani F. Increased expression of axogenesis-related genes and mossy fibre length in dentate granule cells from adult HuD overexpressor mice. ASN Neuro. 2011;3:259&#x2013;270. doi: 10.1042/AN20110015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/AN20110015</ArticleId><ArticleId IdType="pmc">PMC3234101</ArticleId><ArticleId IdType="pubmed">22004431</ArticleId></ArticleIdList></Reference><Reference><Citation>Mobarak C.D., Anderson K.D., Morin M., Beckel-Mitchener A., Rogers S.L., Furneaux H., King P., Perrone-Bizzozero N.I. The RNA-binding protein HuD is required for GAP-43 mRNA stability, GAP-43 gene expression, and PKC-dependent neurite outgrowth in PC12 cells. Mol. Biol. Cell. 2000;11:3191&#x2013;3203. doi: 10.1091/mbc.11.9.3191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.11.9.3191</ArticleId><ArticleId IdType="pmc">PMC14985</ArticleId><ArticleId IdType="pubmed">10982410</ArticleId></ArticleIdList></Reference><Reference><Citation>Akten B., Kye M.J., Hao L.T., Wertz M.H., Singh S., Nie D., Huang J., Merianda T.T., Twiss J.L., Beattie C.E., et al. Interaction of survival of motor neuron (SMN) and HuD proteins with mRNA cpg15 rescues motor neuron axonal deficits. Proc. Natl. Acad. Sci. USA. 2011;108:10337&#x2013;10342. doi: 10.1073/pnas.1104928108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1104928108</ArticleId><ArticleId IdType="pmc">PMC3121858</ArticleId><ArticleId IdType="pubmed">21652774</ArticleId></ArticleIdList></Reference><Reference><Citation>Deschenes-Furry J., Belanger G., Perrone-Bizzozero N., Jasmin B.J. Post-transcriptional regulation of acetylcholinesterase mRNAs in nerve growth factor-treated PC12 cells by the RNA-binding protein HuD. J. Biol. Chem. 2003;278:5710&#x2013;5717. doi: 10.1074/jbc.M209383200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M209383200</ArticleId><ArticleId IdType="pubmed">12468554</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasashima K., Terashima K., Yamamoto K., Sakashita E., Sakamoto H. Cytoplasmic localization is required for the mammalian ELAV-like protein HuD to induce neuronal differentiation. Genes Cells. 1999;4:667&#x2013;683. doi: 10.1046/j.1365-2443.1999.00292.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2443.1999.00292.x</ArticleId><ArticleId IdType="pubmed">10620013</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascale A., Gusev P.A., Amadio M., Dottorini T., Govoni S., Alkon D.L., Quattrone A. Increase of the RNA-binding protein HuD and posttranscriptional up-regulation of the GAP-43 gene during spatial memory. Proc. Natl. Acad. Sci. USA. 2004;101:1217&#x2013;1222. doi: 10.1073/pnas.0307674100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0307674100</ArticleId><ArticleId IdType="pmc">PMC337033</ArticleId><ArticleId IdType="pubmed">14745023</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo S., Kim H.H., Kim P., Donnelly C.J., Kalinski A.L., Vuppalanchi D., Park M., Lee S.J., Merianda T.T., Perrone-Bizzozero N.I., et al. A HuD-ZBP1 ribonucleoprotein complex localizes GAP-43 mRNA into axons through its 3&#x2019; untranslated region AU-rich regulatory element. J. Neurochem. 2013;126:792&#x2013;804. doi: 10.1111/jnc.12266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12266</ArticleId><ArticleId IdType="pmc">PMC3766383</ArticleId><ArticleId IdType="pubmed">23586486</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C., Lee S.J., Gardiner A.S., Smith T., Sahoo P.K., Patel P., Thames E., Rodriguez R., Taylor R., Yoo S., et al. Axonal localization of neuritin/CPG15 mRNA is limited by competition for HuD binding. J. Cell Sci. 2017;130:3650&#x2013;3662. doi: 10.1242/jcs.201244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.201244</ArticleId><ArticleId IdType="pmc">PMC5702053</ArticleId><ArticleId IdType="pubmed">28871047</ArticleId></ArticleIdList></Reference><Reference><Citation>Javaherian A., Cline H.T. Coordinated motor neuron axon growth and neuromuscular synaptogenesis are promoted by CPG15 in vivo. Neuron. 2005;45:505&#x2013;512. doi: 10.1016/j.neuron.2004.12.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.12.051</ArticleId><ArticleId IdType="pubmed">15721237</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung M., Lee E.K. RNA-Binding Protein HuD as a Versatile Factor in Neuronal and Non-Neuronal Systems. Biology. 2021;10:361. doi: 10.3390/biology10050361.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10050361</ArticleId><ArticleId IdType="pmc">PMC8145660</ArticleId><ArticleId IdType="pubmed">33922479</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone-Bizzozero N., Bird C.W. Role of HuD in nervous system function and pathology. Front. Biosci. 2013;5:554&#x2013;563. doi: 10.2741/S389.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/S389</ArticleId><ArticleId IdType="pubmed">23277068</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi S., Yano M., Igarashi M., Okano H.J., Okano H. Alternative role of HuD splicing variants in neuronal differentiation. J. Neurosci. Res. 2015;93:399&#x2013;409. doi: 10.1002/jnr.23496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23496</ArticleId><ArticleId IdType="pubmed">25332105</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito K., Fujiwara T., Katahira J., Inoue K., Sakamoto H. TAP/NXF1, the primary mRNA export receptor, specifically interacts with a neuronal RNA-binding protein HuD. Biochem. Biophys. Res. Commun. 2004;321:291&#x2013;297. doi: 10.1016/j.bbrc.2004.06.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2004.06.140</ArticleId><ArticleId IdType="pubmed">15358174</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H., Hasman R.A., Barron V.A., Luo G., Lou H. A nuclear function of Hu proteins as neuron-specific alternative RNA processing regulators. Mol. Biol. Cell. 2006;17:5105&#x2013;5114. doi: 10.1091/mbc.e06-02-0099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e06-02-0099</ArticleId><ArticleId IdType="pmc">PMC1679676</ArticleId><ArticleId IdType="pubmed">17035636</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman A.J., Hafez A.K., Amoah S.K., Rodriguez B.A., Dell&#x2019;Orco M., Lozano E., Hartley B.J., Alural B., Lalonde J., Chander P., et al. A psychiatric disease-related circular RNA controls synaptic gene expression and cognition. Mol. Psychiatry. 2020;25:2712&#x2013;2727. doi: 10.1038/s41380-020-0653-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-0653-4</ArticleId><ArticleId IdType="pmc">PMC7577899</ArticleId><ArticleId IdType="pubmed">31988434</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell&#x2019;Orco M., Oliver R.J., Perrone-Bizzozero N. HuD Binds to and Regulates Circular RNAs Derived From Neuronal Development- and Synaptic Plasticity-Associated Genes. Front. Genet. 2020;11:790. doi: 10.3389/fgene.2020.00790.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2020.00790</ArticleId><ArticleId IdType="pmc">PMC7419605</ArticleId><ArticleId IdType="pubmed">32849796</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell&#x2019;Orco M., Elyaderani A., Vannan A., Sekar S., Powell G., Liang W.S., Neisewander J.L., Perrone-Bizzozero N.I. HuD Regulates mRNA-circRNA-miRNA Networks in the Mouse Striatum Linked to Neuronal Development and Drug Addiction. Biology. 2021;10:939. doi: 10.3390/biology10090939.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10090939</ArticleId><ArticleId IdType="pmc">PMC8468275</ArticleId><ArticleId IdType="pubmed">34571817</ArticleId></ArticleIdList></Reference><Reference><Citation>Deschenes-Furry J., Mousavi K., Bolognani F., Neve R.L., Parks R.J., Perrone-Bizzozero N.I., Jasmin B.J. The RNA&#x2013;binding protein HuD binds acetylcholinesterase mRNA in neurons and regulates its expression after axotomy. J. Neurosci. 2007;27:665&#x2013;675. doi: 10.1523/JNEUROSCI.4626-06.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4626-06.2007</ArticleId><ArticleId IdType="pmc">PMC6672799</ArticleId><ArticleId IdType="pubmed">17234598</ArticleId></ArticleIdList></Reference><Reference><Citation>Amadio M., Pascale A., Wang J., Ho L., Quattrone A., Gandy S., Haroutunian V., Racchi M., Pasinetti G.M. nELAV proteins alteration in Alzheimer&#x2019;s disease brain: A novel putative target for amyloid-beta reverberating on AbetaPP processing. J. Alzheimers Dis. 2009;16:409&#x2013;419. doi: 10.3233/JAD-2009-0967.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2009-0967</ArticleId><ArticleId IdType="pmc">PMC6057145</ArticleId><ArticleId IdType="pubmed">19221430</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang M.-J., Abdelmohsen K., Hutchison E.R., Mitchell S.J., Grammatikakis I., Guo R., Noh J.H., Martindale J.L., Yang X., Lee E.K., et al. HuD regulates coding and noncoding RNA to induce APP&#x2192;A&#x3b2; processing. Cell Rep. 2014;7:1401&#x2013;1409. doi: 10.1016/j.celrep.2014.04.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.04.050</ArticleId><ArticleId IdType="pmc">PMC4074355</ArticleId><ArticleId IdType="pubmed">24857657</ArticleId></ArticleIdList></Reference><Reference><Citation>Fragkouli A., Koukouraki P., Vlachos I.S., Paraskevopoulou M.D., Hatzigeorgiou A.G., Doxakis E. Neuronal ELAVL proteins utilize AUF&#x2013;1 as a co&#x2013;partner to induce neuron&#x2013;specific alternative splicing of APP. Sci. Rep. 2017;7:44507. doi: 10.1038/srep44507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44507</ArticleId><ArticleId IdType="pmc">PMC5349543</ArticleId><ArticleId IdType="pubmed">28291226</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastic A., Negeri O., Ravel-Chapuis A., Savard A., Trung M.T., Palidwor G., Guo H., Marcogliese P., Taylor J.A., Okano H., et al. LRRK2 Phosphorylates Neuronal Elav RNA-Binding Proteins to Regulate Phenotypes Relevant to Parkinson&#x2019;s Disease. bioRxiv. 2022 doi: 10.1101/2022.04.24.489327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.04.24.489327</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim C.S., Alkon D.L. Protein kinase C stimulates HuD&#x2013;mediated mRNA stability and protein expression of neurotrophic factors and enhances dendritic maturation of hippocampal neurons in culture. Hippocampus. 2012;22:2303&#x2013;2319. doi: 10.1002/hipo.22048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.22048</ArticleId><ArticleId IdType="pubmed">22736542</ArticleId></ArticleIdList></Reference><Reference><Citation>Sosanya N.M., Cacheaux L.P., Workman E.R., Niere F., Perrone-Bizzozero N.I., Raab-Graham K.F. Mammalian Target of Rapamycin (mTOR) Tagging Promotes Dendritic Branch Variability through the Capture of Ca2+/Calmodulin&#x2013;dependent Protein Kinase II alpha (CaMKIIalpha) mRNAs by the RNA&#x2013;binding Protein HuD. J. Biol. Chem. 2015;290:16357&#x2013;16371. doi: 10.1074/jbc.M114.599399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.599399</ArticleId><ArticleId IdType="pmc">PMC4481233</ArticleId><ArticleId IdType="pubmed">25944900</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph B., Orlian M., Furneaux H. p21(waf1) mRNA contains a conserved element in its 3&#x2032;&#x2013;untranslated region that is bound by the Elav&#x2013;like mRNA&#x2013;stabilizing proteins. J. Biol. Chem. 1998;273:20511&#x2013;20516. doi: 10.1074/jbc.273.32.20511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.32.20511</ArticleId><ArticleId IdType="pubmed">9685407</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckel-Mitchener A.C., Miera A., Keller R., Perrone-Bizzozero N.I. Poly(A) tail length&#x2013;dependent stabilization of GAP&#x2013;43 mRNA by the RNA&#x2013;binding protein HuD. J. Biol. Chem. 2002;277:27996&#x2013;28002. doi: 10.1074/jbc.M201982200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M201982200</ArticleId><ArticleId IdType="pubmed">12034726</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince-Dunn G., Okano H.J., Jensen K.B., Park W.Y., Zhong R., Ule J., Mele A., Fak J.J., Yang C., Zhang C., et al. Neuronal Elav&#x2013; like (Hu) proteins regulate RNA splicing and abundance to control glutamate levels and neuronal excitability. Neuron. 2012;75:1067&#x2013;1080. doi: 10.1016/j.neuron.2012.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.07.009</ArticleId><ArticleId IdType="pmc">PMC3517991</ArticleId><ArticleId IdType="pubmed">22998874</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross R.A., Lazarova D.L., Manley G.T., Smitt P.S., Spengler B.A., Posner J.B., Biedler J.L. HuD, a neuronal&#x2013;specific RNA&#x2013; binding protein, is a potential regulator of MYCN expression in human neuroblastoma cells. Eur. J. Cancer. 1997;33:2071&#x2013;2074. doi: 10.1016/S0959-8049(97)00331-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0959-8049(97)00331-6</ArticleId><ArticleId IdType="pubmed">9516855</ArticleId></ArticleIdList></Reference><Reference><Citation>Manohar C.F., Short M.L., Nguyen A., Nguyen N.N., Chagnovich D., Yang Q., Cohn S.L. HuD, a neuronal&#x2013;specific RNA&#x2013; binding protein, increases the in vivo stability of MYCN RNA. J. Biol. Chem. 2002;277:1967&#x2013;1973. doi: 10.1074/jbc.M106966200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M106966200</ArticleId><ArticleId IdType="pubmed">11711535</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z.H., Li S.J., Qi Y., Zhao J.J., Liu X.Y., Han Y., Xu P., Chen X.H. HuD regulates the cpg15 expression via the 3&#x2032;&#x2013;UTR and AU&#x2013;rich element. Neurochem. Res. 2011;36:1027&#x2013;1036. doi: 10.1007/s11064-011-0443-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-011-0443-0</ArticleId><ArticleId IdType="pubmed">21424739</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H., Hinman M.N., Hasman R.A., Mehta P., Lou H. Regulation of neuron&#x2013;specific alternative splicing of neurofibromatosis type 1 pre&#x2013;mRNA. Mol. Cell Biol. 2008;28:1240&#x2013;1251. doi: 10.1128/MCB.01509-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01509-07</ArticleId><ArticleId IdType="pmc">PMC2258745</ArticleId><ArticleId IdType="pubmed">18086893</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H.L., Hinman M.N., Barron V.A., Geng C., Zhou G., Luo G., Siegel R.E., Lou H. Hu proteins regulate alternative splicing by inducing localized histone hyperacetylation in an RNA&#x2013;dependent manner. Proc. Natl. Acad. Sci. USA. 2011;108:E627&#x2013;E635. doi: 10.1073/pnas.1103344108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1103344108</ArticleId><ArticleId IdType="pmc">PMC3169152</ArticleId><ArticleId IdType="pubmed">21808035</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuadrado A., Navarro-Yubero C., Furneaux H., Kinter J., Sonderegger P., Munoz A. HuD binds to three AU&#x2013;rich sequences in the 3&#x2032;&#x2013;UTR of neuroserpin mRNA and promotes the accumulation of neuroserpin mRNA and protein. Nucleic Acids Res. 2002;30:2202&#x2013;2211. doi: 10.1093/nar/30.10.2202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/30.10.2202</ArticleId><ArticleId IdType="pmc">PMC115279</ArticleId><ArticleId IdType="pubmed">12000840</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Fallini C., Colombrita C., Pascale A., Laforenza U., Quattrone A., Silani V. Post&#x2013;transcriptional regulation of neuro&#x2013;oncological ventral antigen 1 by the neuronal RNA&#x2013;binding proteins ELAV. J. Biol. Chem. 2008;283:7531&#x2013;7541. doi: 10.1074/jbc.M706082200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M706082200</ArticleId><ArticleId IdType="pubmed">18218628</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Fallini C., Cova L., Fantozzi R., Calzarossa C., Zennaro E., Pascale A., Quattrone A., Silani V. A role for the ELAV RNA&#x2013;binding proteins in neural stem cells: Stabilization of Msi1 mRNA. J. Cell Sci. 2006;119:1442&#x2013;1452. doi: 10.1242/jcs.02852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.02852</ArticleId><ArticleId IdType="pubmed">16554442</ArticleId></ArticleIdList></Reference><Reference><Citation>Sosanya N.M., Huang P.P.C., Cacheaux L.P., Chen C.J., Nguyen K., Perrone-Bizzozero N.I., Raab-Graham K.F. Degradation of high affinity HuD targets releases Kv1.1 mRNA from miR&#x2013;129 repression by mTORCJ. Cell Biol. 2013;202:53&#x2013;69. doi: 10.1083/jcb.201212089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201212089</ArticleId><ArticleId IdType="pmc">PMC3704988</ArticleId><ArticleId IdType="pubmed">23836929</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Tidei J.J., Polich E.D., Gao Y., Zhao H., Perrone&#x2013;Bizzozero N.I., Guo W., Zhao X. Positive feedback between RNA&#x2013; binding protein HuD and transcription factor SATB1 promotes neurogenesis. Proc. Natl. Acad. Sci. USA. 2015;112:E4995&#x2013;E5004. doi: 10.1073/pnas.1513780112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1513780112</ArticleId><ArticleId IdType="pmc">PMC4568658</ArticleId><ArticleId IdType="pubmed">26305964</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell&#x2019;Orco M., Sardone V., Gardiner A.S., Pansarasa O., Bordoni M., Perrone-Bizzozero N.I., Cereda C. HuD regulates SOD1 expression during oxidative stress in differentiated neuroblastoma cells and sporadic ALS motor cortex. Neurobiol. Dis. 2021;148:105211. doi: 10.1016/j.nbd.2020.105211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105211</ArticleId><ArticleId IdType="pubmed">33271327</ArticleId></ArticleIdList></Reference><Reference><Citation>Atlas R., Behar L., Elliott E., Ginzburg I. The insulin&#x2013;like growth factor mRNA binding&#x2013;protein IMP&#x2013;1 and the Ras&#x2013;regulatory protein G3BP associate with tau mRNA and HuD protein in differentiated P19 neuronal cells. J. Neurochem. 2004;89:613&#x2013;626. doi: 10.1111/j.1471-4159.2004.02371.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02371.x</ArticleId><ArticleId IdType="pubmed">15086518</ArticleId></ArticleIdList></Reference><Reference><Citation>Noureddine M.A., Qin X.-J., Oliveira S.A., Skelly T.J., van der Walt J., Hauser M.A., Pericak-Vance M.A., Vance J.M., Li Y.-J. Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease. Hum. Genet. 2005;117:27&#x2013;33. doi: 10.1007/s00439-005-1259-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-005-1259-2</ArticleId><ArticleId IdType="pubmed">15827745</ArticleId></ArticleIdList></Reference><Reference><Citation>Haugarvoll K., Toft M., Ross O.A., Stone J.T., Heckman M.G., White L.R., Lynch T., Gibson J.M., Wszolek Z.K., Uitti R.J., et al. ELAVL4, PARK10, and the Celts. Mov. Disord. 2007;22:585&#x2013;587. doi: 10.1002/mds.21336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.21336</ArticleId><ArticleId IdType="pubmed">17230446</ArticleId></ArticleIdList></Reference><Reference><Citation>DeStefano A.L., Latourelle J., Lew M.F., Suchowersky O., Klein C., Golbe L.I., Mark M.H., Growdon J.H., Wooten G.F., Watts R., et al. Replication of association between ELAVL4 and Parkinson disease: The GenePD study. Hum. Genet. 2008;124:95&#x2013;99. doi: 10.1007/s00439-008-0526-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-008-0526-4</ArticleId><ArticleId IdType="pmc">PMC2716559</ArticleId><ArticleId IdType="pubmed">18587682</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascale A., Amadio M., Scapagnini G., Lanni C., Racchi M., Provenzani A., Govoni S., Alkon D.L., Quattrone A. Neuronal ELAV proteins enhance mRNA stability by a PKCalpha-dependent pathway. Proc. Natl. Acad. Sci. USA. 2005;102:12065&#x2013;12070. doi: 10.1073/pnas.0504702102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0504702102</ArticleId><ArticleId IdType="pmc">PMC1189326</ArticleId><ArticleId IdType="pubmed">16099831</ArticleId></ArticleIdList></Reference><Reference><Citation>Subhadra B., Schaller K., Seeds N.W. Neuroserpin up-regulation in the Alzheimer&#x2019;s disease brain is associated with elevated thyroid hormone receptor-&#x3b2;1 and HuD expression. Neurochem. Int. 2013;63:476&#x2013;481. doi: 10.1016/j.neuint.2013.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2013.08.010</ArticleId><ArticleId IdType="pmc">PMC3902180</ArticleId><ArticleId IdType="pubmed">24036060</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Linden R.J., Gerritsen J.S., Liao M., Widomska J., Pearse R.V., White F.M., Franke B., Young-Pearse T.L., Poelmans G. RNA-binding protein ELAVL4/HuD ameliorates Alzheimer&#x2019;s disease-related molecular changes in human iPSC-derived neurons. Prog. Neurobiol. 2022;217:102316. doi: 10.1016/j.pneurobio.2022.102316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2022.102316</ArticleId><ArticleId IdType="pubmed">35843356</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffreda A., Nizzardo M., Arosio A., Ruepp M.-D., Calogero R.A., Volinia S., Galasso M., Bendotti C., Ferrarese C., Lunetta C., et al. miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis. Prog. Neurobiol. 2020;190:101803. doi: 10.1016/j.pneurobio.2020.101803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2020.101803</ArticleId><ArticleId IdType="pubmed">32335272</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis R., Santini L., Colantoni A., Peruzzi G., de Turris V., Alfano V., Bozzoni I., Rosa A. FUS Mutant Human Motoneurons Display Altered Transcriptome and microRNA Pathways with Implications for ALS Pathogenesis. Stem Cell Rep. 2017;9:1450&#x2013;1462. doi: 10.1016/j.stemcr.2017.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.09.004</ArticleId><ArticleId IdType="pmc">PMC5830977</ArticleId><ArticleId IdType="pubmed">28988989</ArticleId></ArticleIdList></Reference><Reference><Citation>Garone M.G., Birsa N., Rosito M., Salaris F., Mochi M., de Turris V., Nair R.R., Cunningham T.J., Fisher E.M.C., Morlando M., et al. ALS-related FUS mutations alter axon growth in motoneurons and affect HuD/ELAVL4 and FMRP activity. Commun. Biol. 2021;4:1025. doi: 10.1038/s42003-021-02538-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02538-8</ArticleId><ArticleId IdType="pmc">PMC8410767</ArticleId><ArticleId IdType="pubmed">34471224</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A.M., Koppers M., Groen E.J.N., van den Heuvel D.M.A., Dini Modigliani S., Anink J.J., Fumoto K., van Diggelen F., Snelting A., Sodaar P., et al. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways. Acta Neuropathol. 2016;132:175&#x2013;196. doi: 10.1007/s00401-016-1575-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1575-8</ArticleId><ArticleId IdType="pmc">PMC4947123</ArticleId><ArticleId IdType="pubmed">27164932</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis R., Alfano V., de Turris V., Colantoni A., Santini L., Garone M.G., Antonacci G., Peruzzi G., Sudria-Lopez E., Wyler E., et al. Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in Amyotrophic Lateral Sclerosis. Cell Rep. 2019;27:3818&#x2013;3831. e5. doi: 10.1016/j.celrep.2019.05.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.05.085</ArticleId><ArticleId IdType="pmc">PMC6613039</ArticleId><ArticleId IdType="pubmed">31242416</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolosa E., Garrido A., Scholz S.W., Poewe W. Challenges in the diagnosis of Parkinson&#x2019;s disease. Lancet Neurol. 2021;20:385&#x2013;397. doi: 10.1016/S1474-4422(21)00030-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00030-2</ArticleId><ArticleId IdType="pmc">PMC8185633</ArticleId><ArticleId IdType="pubmed">33894193</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubers L., Valderrama-Carvajal H., Laframboise J., Timbers J., Sanchez G., C&#xf4;t&#xe9; J. HuD interacts with survival motor neuron protein and can rescue spinal muscular atrophy-like neuronal defects. Hum. Mol. Genet. 2011;20:553&#x2013;579. doi: 10.1093/hmg/ddq500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq500</ArticleId><ArticleId IdType="pubmed">21088113</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohm M., May C., Marcus K., Steinbach S., Theis V., Theiss C., Matschke V. The microRNA miR-375-3p and the Tumor Suppressor NDRG2 are Involved in Sporadic Amyotrophic Lateral Sclerosis. Cell. Physiol. Biochem. 2019;52:1412&#x2013;1426.</Citation><ArticleIdList><ArticleId IdType="pubmed">31075191</ArticleId></ArticleIdList></Reference><Reference><Citation>Garone M.G., Alfano V., Salvatori B., Braccia C., Peruzzi G., Colantoni A., Bozzoni I., Armirotti A., Rosa A. Proteomics analysis of FUS mutant human motoneurons reveals altered regulation of cytoskeleton and other ALS-linked proteins via 3&#x2019;UTR binding. Sci. Rep. 2020;10:11827. doi: 10.1038/s41598-020-68794-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-68794-6</ArticleId><ArticleId IdType="pmc">PMC7366621</ArticleId><ArticleId IdType="pubmed">32678235</ArticleId></ArticleIdList></Reference><Reference><Citation>Birsa N., Ule A.M., Garone M.G., Tsang B., Mattedi F., Chong P.A., Humphrey J., Jarvis S., Pisiren M., Wilkins O.G., et al. FUS-ALS mutants alter FMRP phase separation equilibrium and impair protein translation. Sci. Adv. 2021;7:eabf8660. doi: 10.1126/sciadv.abf8660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abf8660</ArticleId><ArticleId IdType="pmc">PMC8294762</ArticleId><ArticleId IdType="pubmed">34290090</ArticleId></ArticleIdList></Reference><Reference><Citation>Garone M.G., Salerno D., Rosa A. Digital color-coded molecular barcoding reveals dysregulation of common FUS and FMRP targets in soma and neurites of ALS mutant motoneurons. bioRxiv. 2022 doi: 10.1101/2022.08.02.502510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.02.502510</ArticleId></ArticleIdList></Reference><Reference><Citation>Tebaldi T., Zuccotti P., Peroni D., K&#xf6;hn M., Gasperini L., Potrich V., Bonazza V., Dudnakova T., Rossi A., Sanguinetti G., et al. HuD Is a Neural Translation Enhancer Acting on mTORC1-Responsive Genes and Counteracted by the Y3 Small Non-coding RNA. Mol. Cell. 2018;71:256&#x2013;270.e10. doi: 10.1016/j.molcel.2018.06.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.06.032</ArticleId><ArticleId IdType="pmc">PMC6060611</ArticleId><ArticleId IdType="pubmed">30029004</ArticleId></ArticleIdList></Reference><Reference><Citation>Errichelli L., Dini Modigliani S., Laneve P., Colantoni A., Legnini I., Capauto D., Rosa A., De Santis R., Scarf&#xf2; R., Peruzzi G., et al. FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons. Nat. Commun. 2017;8:14741. doi: 10.1038/ncomms14741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14741</ArticleId><ArticleId IdType="pmc">PMC5379105</ArticleId><ArticleId IdType="pubmed">28358055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripin N., Parker R. Are stress granules the RNA analogs of misfolded protein aggregates? RNA. 2022;28:67&#x2013;75. doi: 10.1261/rna.079000.121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.079000.121</ArticleId><ArticleId IdType="pmc">PMC8675284</ArticleId><ArticleId IdType="pubmed">34670846</ArticleId></ArticleIdList></Reference><Reference><Citation>Barresi V., Musmeci C., Rinaldi A., Condorelli D.F. Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets. Int. J. Mol. Sci. 2022;23:8875. doi: 10.3390/ijms23168875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23168875</ArticleId><ArticleId IdType="pmc">PMC9408055</ArticleId><ArticleId IdType="pubmed">36012138</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollasalehi N., Francois-Moutal L., Porciani D., Burke D.H., Khanna M. Aptamers Targeting Hallmark Proteins of Neurodegeneration. Nucleic Acid. Ther. 2022;32:235&#x2013;250. doi: 10.1089/nat.2021.0091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/nat.2021.0091</ArticleId><ArticleId IdType="pubmed">35452303</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacco E., Kantelberg O., Milanetti E., Armaos A., Panei F.P., Gregory J., Jeacock K., Clarke D.J., Chandran S., Ruocco G., et al. Probing TDP-43 condensation using an in silico designed aptamer. Nat. Commun. 2022;13:3306. doi: 10.1038/s41467-022-30944-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30944-x</ArticleId><ArticleId IdType="pmc">PMC9226187</ArticleId><ArticleId IdType="pubmed">35739092</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Hu C., Moufawad El Achkar C., Black L.E., Douville J., Larson A., Pendergast M.K., Goldkind S.F., Lee E.A., Kuniholm A., et al. Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease. N. Engl. J. Med. 2019;381:1644&#x2013;1652. doi: 10.1056/NEJMoa1813279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1813279</ArticleId><ArticleId IdType="pmc">PMC6961983</ArticleId><ArticleId IdType="pubmed">31597037</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>